MELINDA RUSNACK: Open Payments
NPI 1720717663 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,166 in 116 payments from 17 companies in 2025. Trend: 2023 $1,782 · 2024 $1,696 · 2025 $2,166
Food & beverage: $2,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $753 |
| PFIZER INC. | 23 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $184 |
| Aimmune Therapeutics, Inc. | 7 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $140 |
| Janssen Biotech, Inc. | 9 | $139 |
| Ardelyx, Inc. | 6 | $128 |
| Boston Scientific Corporation | 2 | $87 |
| GENZYME CORPORATION | 2 | $62 |
| Celltrion USA Inc. | 2 | $43 |
Products named: RINVOQ, VELSIPITY, SKYRIZI, ZENPEP, TREMFYA, XELJANZ, IBSRELA, ENTYVIO.
Industry payments across NC — which companies pay providers there.
